blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3246328

EP3246328 - QUINAZOLINE HETEROCYCLIC COMPOUND AS EGFR KINASE INHIBITOR, AND PREPARATION AND APPLICATION THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.05.2021
Database last updated on 31.08.2024
FormerThe patent has been granted
Status updated on  19.06.2020
FormerGrant of patent is intended
Status updated on  01.01.2020
FormerExamination is in progress
Status updated on  07.12.2018
FormerRequest for examination was made
Status updated on  20.10.2017
FormerThe international publication has been made
Status updated on  07.07.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Beijing Scitech-MQ Pharmaceuticals Limited
No.10 Linhe North Street
Shunyi District
Beijing 101300 / CN
[2020/30]
Former [2017/47]For all designated states
Beijing Scitech-MQ Pharmaceuticals Limited
No.10 Linhe North Street
Shunyi District
Beijing 101300 / CN
Inventor(s)01 / SHENG, Wang
No.10 Linhe North Street
Shunyi District
Beijing 101300 / CN
02 / YANG, Leifu
No.10 Linhe North Street
Shunyi District
Beijing 101300 / CN
03 / PAN, Zhiyong
No.10 Linhe North Street
Shunyi District
Beijing 101300 / CN
 [2017/47]
Representative(s)Kayahan, Senem, et al
Yalciner Patent and Consulting Ltd.
Tunus Cad. No: 85/3-4
Kavaklidere Cankaya
06680 Ankara / TR
[2020/30]
Former [2017/47]Karaahmet, Erdogan
Yalciner Patent and Consulting Ltd.
Tunus Cad. 85/3-4
Kavaklidere
Cankaya
06680 Ankara / TR
Application number, filing date16737072.512.01.2016
[2017/47]
WO2016CN70736
Priority number, dateCN2015101541113.01.2015         Original published format: CN201510015411
[2017/47]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016112847
Date:21.07.2016
Language:ZH
[2016/29]
Type: A1 Application with search report 
No.:EP3246328
Date:22.11.2017
Language:EN
[2017/47]
Type: B1 Patent specification 
No.:EP3246328
Date:22.07.2020
Language:EN
[2020/30]
Search report(s)International search report - published on:CN21.07.2016
(Supplementary) European search report - dispatched on:EP08.05.2018
ClassificationIPC:C07D491/056, C07D498/04, A61P35/00, A61P35/02, A61K31/5375
[2018/23]
CPC:
A61P35/02 (EP,US); C07D491/056 (EP,CN,US); C07D239/94 (US);
A61K31/357 (EP,US); A61K31/517 (EP,US); A61K31/5375 (EP,US);
A61K39/3955 (US); C07D405/14 (US); C07D498/04 (EP,CN,US);
A61K2300/00 (US) (-)
Former IPC [2017/47]C07D491/056, C07D498/04, A61P35/00, A61P35/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/47]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:HETEROCYCLISCHE CHINAZOLINVERBINDUNG ALS EGFR-KINASE-INHIBITOREN SOWIE HERSTELLUNG UND ANWENDUNG DAVON[2017/47]
English:QUINAZOLINE HETEROCYCLIC COMPOUND AS EGFR KINASE INHIBITOR, AND PREPARATION AND APPLICATION THEREOF[2017/47]
French:COMPOSÉ HÉTÉROCYCLIQUE QUINAZOLÉINE COMME INHIBITEUR DE L'EGFR KINASE, SON PROCÉDÉ DE PRÉPARATION ET SON APPLICATION[2017/47]
Entry into regional phase07.07.2017Translation filed 
10.07.2017National basic fee paid 
10.07.2017Search fee paid 
10.07.2017Designation fee(s) paid 
10.07.2017Examination fee paid 
Examination procedure07.07.2017Date on which the examining division has become responsible
10.07.2017Examination requested  [2017/47]
25.07.2018Amendment by applicant (claims and/or description)
11.12.2018Despatch of a communication from the examining division (Time limit: M04)
01.04.2019Reply to a communication from the examining division
04.07.2019Despatch of a communication from the examining division (Time limit: M02)
01.08.2019Reply to a communication from the examining division
02.01.2020Communication of intention to grant the patent
10.03.2020Fee for grant paid
10.03.2020Fee for publishing/printing paid
10.03.2020Receipt of the translation of the claim(s)
Opposition(s)23.04.2021No opposition filed within time limit [2021/26]
Fees paidRenewal fee
09.11.2017Renewal fee patent year 03
17.12.2018Renewal fee patent year 04
10.01.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.01.2016
AL22.07.2020
AT22.07.2020
CY22.07.2020
CZ22.07.2020
DK22.07.2020
EE22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
IT22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
MK22.07.2020
NL22.07.2020
PL22.07.2020
RO22.07.2020
RS22.07.2020
SE22.07.2020
SI22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
IE12.01.2021
LU12.01.2021
BE31.01.2021
CH31.01.2021
LI31.01.2021
[2024/22]
Former [2023/30]HU12.01.2016
AL22.07.2020
AT22.07.2020
CY22.07.2020
CZ22.07.2020
DK22.07.2020
EE22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
IT22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
NL22.07.2020
PL22.07.2020
RO22.07.2020
RS22.07.2020
SE22.07.2020
SI22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
IE12.01.2021
LU12.01.2021
BE31.01.2021
CH31.01.2021
LI31.01.2021
Former [2023/27]HU12.01.2016
AL22.07.2020
AT22.07.2020
CZ22.07.2020
DK22.07.2020
EE22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
IT22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
NL22.07.2020
PL22.07.2020
RO22.07.2020
RS22.07.2020
SE22.07.2020
SI22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
IE12.01.2021
LU12.01.2021
BE31.01.2021
CH31.01.2021
LI31.01.2021
Former [2022/33]AL22.07.2020
AT22.07.2020
CZ22.07.2020
DK22.07.2020
EE22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
IT22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
NL22.07.2020
PL22.07.2020
RO22.07.2020
RS22.07.2020
SE22.07.2020
SI22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
IE12.01.2021
LU12.01.2021
BE31.01.2021
CH31.01.2021
LI31.01.2021
Former [2022/07]AL22.07.2020
AT22.07.2020
CZ22.07.2020
DK22.07.2020
EE22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
IT22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
NL22.07.2020
PL22.07.2020
RO22.07.2020
RS22.07.2020
SE22.07.2020
SI22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
IE12.01.2021
LU12.01.2021
CH31.01.2021
LI31.01.2021
Former [2021/52]AL22.07.2020
AT22.07.2020
CZ22.07.2020
DK22.07.2020
EE22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
IT22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
NL22.07.2020
PL22.07.2020
RO22.07.2020
RS22.07.2020
SE22.07.2020
SI22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
LU12.01.2021
CH31.01.2021
LI31.01.2021
Former [2021/43]AL22.07.2020
AT22.07.2020
CZ22.07.2020
DK22.07.2020
EE22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
IT22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
NL22.07.2020
PL22.07.2020
RO22.07.2020
RS22.07.2020
SE22.07.2020
SI22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
LU12.01.2021
Former [2021/40]AL22.07.2020
AT22.07.2020
CZ22.07.2020
DK22.07.2020
EE22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
IT22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
NL22.07.2020
PL22.07.2020
RO22.07.2020
RS22.07.2020
SE22.07.2020
SI22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/36]AL22.07.2020
AT22.07.2020
CZ22.07.2020
DK22.07.2020
EE22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
IT22.07.2020
LT22.07.2020
LV22.07.2020
NL22.07.2020
PL22.07.2020
RO22.07.2020
RS22.07.2020
SE22.07.2020
SI22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/28]AL22.07.2020
AT22.07.2020
CZ22.07.2020
DK22.07.2020
EE22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
IT22.07.2020
LT22.07.2020
LV22.07.2020
NL22.07.2020
PL22.07.2020
RO22.07.2020
RS22.07.2020
SE22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/25]AL22.07.2020
AT22.07.2020
CZ22.07.2020
DK22.07.2020
EE22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
IT22.07.2020
LT22.07.2020
LV22.07.2020
NL22.07.2020
PL22.07.2020
RO22.07.2020
RS22.07.2020
SE22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/22]AT22.07.2020
CZ22.07.2020
DK22.07.2020
EE22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
IT22.07.2020
LT22.07.2020
LV22.07.2020
NL22.07.2020
PL22.07.2020
RO22.07.2020
RS22.07.2020
SE22.07.2020
SM22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/20]AT22.07.2020
DK22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
IT22.07.2020
LT22.07.2020
LV22.07.2020
NL22.07.2020
PL22.07.2020
RS22.07.2020
SE22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/17]AT22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
NL22.07.2020
PL22.07.2020
RS22.07.2020
SE22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/10]AT22.07.2020
ES22.07.2020
FI22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
PL22.07.2020
RS22.07.2020
SE22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
IS22.11.2020
PT23.11.2020
Former [2021/09]AT22.07.2020
ES22.07.2020
FI22.07.2020
LT22.07.2020
SE22.07.2020
BG22.10.2020
NO22.10.2020
GR23.10.2020
PT23.11.2020
Former [2021/08]ES22.07.2020
FI22.07.2020
LT22.07.2020
SE22.07.2020
BG22.10.2020
NO22.10.2020
PT23.11.2020
Former [2021/07]FI22.07.2020
LT22.07.2020
NO22.10.2020
Documents cited:Search[Y]WO9749688  (PFIZER [US], et al) [Y] 1-9 * page 10, line 1 - line 5; claim 1 *;
 [Y]WO03082830  (BETA PHARMA INC [US]) [Y] 1-9* claims 1, 20 *
International search[A]WO02088129  (WYETH CORP [US]) [A] 1-5, 7-9 * , the whole document, particularly embodiment *;
 [A]CN1534026  (BEDA MEDICINE CO [US]) [A] 1-5, 7-9 * , the whole document, particularly embodiment *;
 [A]CN101003515  (ASTRAZENECA AB [SE]) [A] 1-5, 7-9 * , the whole document, particularly embodiment *;
 [A]CN102875570  (UNIV ZHEJIANG) [A] 1-4, 6-9 * , the whole document *;
 [A]CN103965211  (JIANGSU AOSAIKANG PHARM CO LTD) [A] 1-4, 6-9* the whole document *;
 [PX]CN104530063  (BEIJING DALITAI PHARMACEUTICAL TECHNOLOGY CO LTD) [PX] 1-9 * , the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.